Swk Holdings Corp. (SWKH) 9.3600 $SWKH
SWK Holdings Corporation Announces 2016 First Quarter Financial Results
GlobeNewswire - Fri May 13, 3:29PM CDT
-- Total revenues of approximately $5.2 million for the first quarter of 2016.
SWK Holdings Corporation Announces 2015 Fourth Quarter and Full-Year Financial Results
GlobeNewswire - Wed Mar 23, 5:00PM CDT
-- Total revenues increased by 35% to approximately $23.5 million for the fiscal year of 2015, compared to $17.4 million for the fiscal year of 2014
SWK Holdings Corporation Announces 2015 Third Quarter Financial Results and Appointment of New CEO
GlobeNewswire - Mon Nov 16, 8:21PM CST
-- Total revenues increased by 53% to approximately $5.7 million for the third quarter of 2015, compared to $3.7 million for the third quarter of 2014
FINRA Announces Effectiveness of SWK Holdings Corporation Stock Split
GlobeNewswire - Tue Oct 06, 4:00PM CDT
On October 6, 2015, the Financial Industry Regulatory Authority, Inc. ("FINRA"
announced on the Daily List the 1:100 reverse stock split followed by a 10:1 forward split for SWK Holdings Corporation (OTCQB:SWKH) ("SWK" or the "Company".
SWK Holdings Corporation Clarifies Timing of Post Split Trading
GlobeNewswire - Wed Sep 16, 6:42PM CDT
SWK Holdings Corporation (OTCQB:SWKH) ("SWK" or the "Company", a life science focused specialty finance company, announced a clarification on the timing of the trading of the Company's common stock on a post-split basis following the execution of the previously announced stock splits effective as of 5:00 p.m. on September 15, 2015.
SWK Holdings Corporation Announces Execution of Stock Split
GlobeNewswire - Tue Sep 15, 4:00PM CDT
SWK Holdings Corporation (OTCQB:SWKH) ("SWK" or the "Company", a life science focused specialty finance company, announced that the previously disclosed 1-for-100 reverse stock split of its common stock, immediately followed by a 10-for-1 forward stock split of its common stock was executed effective as of 5:00 p.m. on September 15, 2015. Beginning with the opening of trading on September 16, 2015, the Company's common stock will trade on OTCQB on a post-split basis under CUSIP number 78501P 203.
SWK Holdings Corporation Announces Timing of Stock Split
GlobeNewswire - Fri Aug 28, 7:00AM CDT
SWK Holdings Corporation (OTCQB:SWKH) ("SWK" or the "Company", a life science focused specialty finance company, today announced a 1-for-100 reverse stock split of its common stock, immediately followed by a 10-for-1 forward stock split of its common stock. The stock splits will be effective as of 5:00 pm Eastern Time September 15, 2015. Beginning with the opening of trading on September 16, 2015, the Company's common stock will trade on OTCQB on a post-split basis. The stock split was approved at SWK's 2015 Annual Meeting of Stockholders held on May 20, 2015.
SWK Holdings Corporation Announces 2015 Second Quarter Financial Results
GlobeNewswire - Fri Aug 14, 7:13AM CDT
-- Total revenues increased by 61% to approximately $5.4 million for the second quarter of 2015, compared to $3.4 million for the second quarter of 2014
Tribute Pharmaceuticals Reports Double Digit Revenue Growth in Third Quarter 2014
Marketwired - Mon Nov 10, 6:32AM CST
Tribute Pharmaceuticals Canada Inc. (OTCQX: TBUFF) (TSX VENTURE: TRX) ("Tribute" or the "Company", a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the US, today announced financial results for its third quarter ending September 30, 2014. In this press release, all dollar amounts are expressed in Canadian currency - unless otherwise noted - and results are reported in accordance with United States generally accepted accounting principles (U.S. GAAP).
TRX.VN: 1.250 (-0.070), NVS: 77.91 (+1.02)
SWK Holdings Corporation Announces 2014 Third Quarter Financial Results and Equity Financing
GlobeNewswire - Mon Nov 03, 3:01PM CST
-- GAAP net income to SWK stockholders of $0.4 million, or $0.01 per share, and, $3.3 million, or $0.07 per share, for the three and nine month periods ending September 30, 2014, respectively, vs. $0.6 million, or $0.01 per share and $1.1 million, or $0.03 per share, for 2013
SWK Holdings Corporation Establishes Record Date for Rights Offering
GlobeNewswire - Mon Oct 20, 4:44PM CDT
SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company", a life science focused specialty finance company, announced that it established a record date for its rights offering. Stockholders of record as of October 30, 2014 will be eligible to participate in the rights offering. As part of the rights offering, holders of shares of common stock will receive non-transferable rights to purchase newly issued shares of common stock of the Company. Each subscription right will entitle stockholders to purchase 0.345662431 shares of common stock of the Company at a subscription price of $0.86 per share. If the rights offering is fully subscribed, the Company expects that the gross proceeds from the rights offering will be approximately $12.5 million. The Company intends to use the proceeds from the rights offering for general corporate purposes.
SWK Holdings Corporation Announces 2016 First Quarter Financial Results
GlobeNewswire - Fri May 13, 3:29PM CDT
-- Total revenues of approximately $5.2 million for the first quarter of 2016.
SWK Holdings Corporation Announces 2015 Fourth Quarter and Full-Year Financial Results
GlobeNewswire - Wed Mar 23, 5:00PM CDT
-- Total revenues increased by 35% to approximately $23.5 million for the fiscal year of 2015, compared to $17.4 million for the fiscal year of 2014
SWK Holdings Corporation Announces 2015 Third Quarter Financial Results and Appointment of New CEO
GlobeNewswire - Mon Nov 16, 8:21PM CST
-- Total revenues increased by 53% to approximately $5.7 million for the third quarter of 2015, compared to $3.7 million for the third quarter of 2014
FINRA Announces Effectiveness of SWK Holdings Corporation Stock Split
GlobeNewswire - Tue Oct 06, 4:00PM CDT
On October 6, 2015, the Financial Industry Regulatory Authority, Inc. ("FINRA"
announced on the Daily List the 1:100 reverse stock split followed by a 10:1 forward split for SWK Holdings Corporation (OTCQB:SWKH) ("SWK" or the "Company". SWK Holdings Corporation Clarifies Timing of Post Split Trading
GlobeNewswire - Wed Sep 16, 6:42PM CDT
SWK Holdings Corporation (OTCQB:SWKH) ("SWK" or the "Company"
, a life science focused specialty finance company, announced a clarification on the timing of the trading of the Company's common stock on a post-split basis following the execution of the previously announced stock splits effective as of 5:00 p.m. on September 15, 2015. SWK Holdings Corporation Announces Execution of Stock Split
GlobeNewswire - Tue Sep 15, 4:00PM CDT
SWK Holdings Corporation (OTCQB:SWKH) ("SWK" or the "Company"
, a life science focused specialty finance company, announced that the previously disclosed 1-for-100 reverse stock split of its common stock, immediately followed by a 10-for-1 forward stock split of its common stock was executed effective as of 5:00 p.m. on September 15, 2015. Beginning with the opening of trading on September 16, 2015, the Company's common stock will trade on OTCQB on a post-split basis under CUSIP number 78501P 203. SWK Holdings Corporation Announces Timing of Stock Split
GlobeNewswire - Fri Aug 28, 7:00AM CDT
SWK Holdings Corporation (OTCQB:SWKH) ("SWK" or the "Company"
, a life science focused specialty finance company, today announced a 1-for-100 reverse stock split of its common stock, immediately followed by a 10-for-1 forward stock split of its common stock. The stock splits will be effective as of 5:00 pm Eastern Time September 15, 2015. Beginning with the opening of trading on September 16, 2015, the Company's common stock will trade on OTCQB on a post-split basis. The stock split was approved at SWK's 2015 Annual Meeting of Stockholders held on May 20, 2015. SWK Holdings Corporation Announces 2015 Second Quarter Financial Results
GlobeNewswire - Fri Aug 14, 7:13AM CDT
-- Total revenues increased by 61% to approximately $5.4 million for the second quarter of 2015, compared to $3.4 million for the second quarter of 2014
Tribute Pharmaceuticals Reports Double Digit Revenue Growth in Third Quarter 2014
Marketwired - Mon Nov 10, 6:32AM CST
Tribute Pharmaceuticals Canada Inc. (OTCQX: TBUFF) (TSX VENTURE: TRX) ("Tribute" or the "Company"
, a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the US, today announced financial results for its third quarter ending September 30, 2014. In this press release, all dollar amounts are expressed in Canadian currency - unless otherwise noted - and results are reported in accordance with United States generally accepted accounting principles (U.S. GAAP). TRX.VN: 1.250 (-0.070), NVS: 77.91 (+1.02)
SWK Holdings Corporation Announces 2014 Third Quarter Financial Results and Equity Financing
GlobeNewswire - Mon Nov 03, 3:01PM CST
-- GAAP net income to SWK stockholders of $0.4 million, or $0.01 per share, and, $3.3 million, or $0.07 per share, for the three and nine month periods ending September 30, 2014, respectively, vs. $0.6 million, or $0.01 per share and $1.1 million, or $0.03 per share, for 2013
SWK Holdings Corporation Establishes Record Date for Rights Offering
GlobeNewswire - Mon Oct 20, 4:44PM CDT
SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"
, a life science focused specialty finance company, announced that it established a record date for its rights offering. Stockholders of record as of October 30, 2014 will be eligible to participate in the rights offering. As part of the rights offering, holders of shares of common stock will receive non-transferable rights to purchase newly issued shares of common stock of the Company. Each subscription right will entitle stockholders to purchase 0.345662431 shares of common stock of the Company at a subscription price of $0.86 per share. If the rights offering is fully subscribed, the Company expects that the gross proceeds from the rights offering will be approximately $12.5 million. The Company intends to use the proceeds from the rights offering for general corporate purposes. 
